Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for Blast-Induced Tinnitus
NCT04066348Phase 2Active, not recruiting
- Sponsor
- Wayne State University
- Start
- Jul 2022
- Primary completion
- Dec 2026
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in tinnitus, sponsored by Wayne State University. Started Jul 2022; status: active, not recruiting.
02
Drugs
etanercept
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT04066348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04066348.